Arthroscopic Instrument Patents: Leaders, Trends & White Space 2026
- 47.1% concentration. The top 5 of 91 ranked assignees account for 359 of 762 records in scope — the rest is a long tail of single- and double-digit filers.
- Filing has cooled from its 2018 peak. Activity peaked at 125 records in 2018; the last complete comparison window shows filings down 47% from 64 in 2021 to 34 in 2024.
- Fluid and imaging claims dominate the record. 84.5% of records carry A61B surgery claims and 34.4% carry A61M fluid-management claims, while image-processing (G06T, 3.5%) and informatics (G16H, 9.3%) remain comparatively open.
Filing growth compares 2021 (64 records) with 2024 (34) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 762 records in scope (CR5), not by the ranked leaders only.
What this landscape covers
This landscape covers arthroscopic instruments and visualization systems — the scopes, cannulas, shaver blades and fluid-management assemblies used in minimally invasive joint surgery, together with the imaging and informatics layers built around them. The scope draws on 762 published records filed between 2015 and mid-2026, searched across instrument, visualization and fluid-handling terms together with claim language on shaver blades, cannula design, image clarity, instrument reach and single-use options.
Filing offices in scope skew heavily toward the United States and Europe, with a meaningful share of PCT (WIPO) filings and secondary activity in Australia and Germany — consistent with a field where clinical adoption and reimbursement pathways are concentrated in a small number of jurisdictions.
Filing trend and technology composition
Two views of the same 762-record dataset: how filing volume has moved year over year, and which IPC subclasses carry the claim density.
Filing trend, 2017-2026
Filings rose to a peak of 125 records in 2018, then eased. The last complete year-over-year comparison available shows a drop from 64 records in 2021 to 34 in 2024, a 47% decline. Counts for 2025 and 2026 are still incomplete because publication typically lags filing by around 18 months, so the most recent bars understate actual filing activity.
Technology composition by IPC subclass
A61B (diagnosis & surgery) touches 84.5% of the 762 records and A61M (devices for body fluids) touches 34.4%, confirming that core instrument and fluid-handling claims are the densest ground. Healthcare informatics (G16H, 9.3%) and image data processing (G06T, 3.5%) sit far behind, and a record can carry more than one class so these shares do not sum to 100%.
Shares are the percentage of the 762 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Arthroscopic Instruments and Visualization with Eureka
This page is one run against one query. Ask Eureka your own question about arthroscopic instruments and visualization and every answer comes back with the patent numbers behind it.
Try EurekaRepresentative filing and the most-cited prior art
Anti-Extravasation Sheath (US20160066949A1, Cannuflow)
An anti-extravasation sheath includes a tube sized and dimensioned to permit fluid flow between the inner surface of the tube and an outer surface of an arthroscopic instrument when the instrument is disposed within the tube. Longitudinal tracts on the inner surface form a seal against the instrument, defining outer lumens, and at least one drainage lumen running within the tracts stays in fluid communication with a drainage path.Filed 2016-03-10 by Cannuflow — illustrative of the cannula/fluid-management claim style that dominates this field's densest IPC classes.
| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US5944715A | Electrosurgical instrument | 2,175 |
| 2 | US6491690B1 | Electrosurgical instrument | 1,978 |
| 3 | WO1999003409A1 | An electrosurgical instrument | 1,935 |
| 4 | WO1999003407A1 | An electrosurgical instrument | 1,934 |
| 5 | US6565560B1 | Electrosurgical instrument | 1,591 |
| 6 | US7278994B2 | Electrosurgical instrument | 1,585 |
| 7 | US20190201045A1 | Method for smoke evacuation for surgical hub | 1,326 |
| 8 | EP0996378B1 | An electrosurgical instrument | 1,258 |
| 9 | US20190201594A1 | Method of sensing particulate from smoke evacuated from a patient, adjusting the pump speed based on the sens… | 1,228 |
| 10 | US20130018400A1 | Status control for electrically powered surgical tool systems | 1,133 |
Citation counts reward age inside this corpus — the most-cited records here date from the electrosurgical-instrument filings of the late 1990s, so treat the ranking as a signal of foundational influence rather than current filing strength.
Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the data means for filing strategy
Three read-outs from the concentration, trend and citation data that matter for where to file next and who to watch.
A small group holds nearly half the field
The five leading assignees account for 359 of the 762 records in scope, with the leader alone credited with 84 records. That density means core cannula, fluid-management and shaver-blade claims are well-occupied ground for new entrants.
Filing has pulled back from its 2018 peak
After peaking at 125 records in 2018, filings fell from 64 in 2021 to 34 in 2024. Recent-year figures for individual assignees show the same pattern, with several leaders recording zero filings in the latest year tracked.
Surgical instrument claims dominate the classification mix
A61B and A61M together touch the large majority of records, meaning fluid-management and core instrument geometry are the most contested claim territory. Imaging and informatics classes are present in far fewer records, suggesting less-crowded claim space there.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to arthroscopic instruments and visualization, with the prior art for and against each one.
Assignee landscape and where activity is thinning
Ninety-one assignees appear in the ranking behind this landscape. Filing is concentrated at the top, but momentum has slowed even among the leaders, and several adjacent claim areas remain comparatively open.
One assignee sets the pace, at real distance from the field
The leading assignee's 84 records sit well above fifth place at 57 and tenth place at 22, showing a steep drop-off rather than a flat distribution across the top ten.
Most assignees hold a handful of records each
Beyond the top ten, filing activity spreads thinly across dozens of companies, each contributing a small number of records rather than sustained filing programs.
Several established filers have gone quiet in the latest tracked year
More than one of the leading assignees recorded zero filings in the most recent year, and one leader's filings dropped 83% year-over-year — consistent with the broader pullback from the 2018 peak.
| Assignee | Recent year | YoY |
|---|---|---|
| Auris Health, Inc. | 1 | -83% |
| Cannuflow, Inc. | 0 | — |
| Ethicon, Inc. | 0 | — |
| Smith & Nephew, Inc. | 0 | -100% |
| Gyrus Medical Limited | 0 | — |
| Relign Corporation | 0 | — |
| Stryker Corporation | 0 | -100% |
| PSIP2 LLC | 0 | — |
Where to take this analysis
The trends here point to specific next steps for teams deciding where to file or partner.
Map claim boundaries around the leading assignee's portfolio
With 84 records held by a single leader and steep concentration in the top five, a freedom-to-operate review of that portfolio's cannula and fluid-management claims should come before any new filing in that space.
Explore assignee portfolios in EurekaTest claim language in the under-claimed informatics and imaging branches
G16H and G06T classes touch a small minority of records, suggesting room for claims that combine visualization hardware with data or image processing without crowding into A61B or A61M territory.
Draft and stress-test claims in EurekaCommon questions on arthroscopic instrument patents
The dataset ranks 91 assignees, with a single leader holding 84 of the 762 records in scope — well ahead of the fifth-ranked assignee at 57 and the tenth at 22. The top five assignees combined hold 359 records, 47.1% of the field, and the top ten hold 72.6%. That leaves a long tail of dozens of companies each contributing only a handful of filings, so competitive risk is concentrated among a small group rather than spread evenly.
Filing peaked at 125 records in 2018 and has since pulled back, with the last complete year-over-year comparison showing a drop from 64 records in 2021 to 34 in 2024, a 47% decline. Figures for 2025 and 2026 are still incomplete because publication typically lags filing by around 18 months, so the most recent years will fill in somewhat as more applications publish. Several individual leading assignees also recorded zero or sharply reduced filings in the latest tracked year, reinforcing the pullback.
Core surgical instrument claims under IPC class A61B appear in 84.5% of the 762 records in scope, and fluid-management claims under A61M appear in 34.4%. These two classes represent the densest claim territory, covering scope geometry, shaver-blade design and fluid handling around the instrument. Because a single record can carry multiple IPC classes, these shares add up to more than 100% and should be read as claim-density signals, not a partition of the field.
Healthcare informatics (G16H) and image data processing (G06T) each touch under 10% of the 762 records, well behind the core surgical and fluid-management classes, suggesting comparatively light claim coverage around data-driven and image-enhancement features layered onto arthroscopic hardware. Single-use cannula seal designs and sterilization-compatible instrument coatings also show lighter representation relative to core cannula and shaver-blade claims. These are the branches worth checking first before assuming freedom to operate, since lighter filing density does not guarantee an empty field.
US20160066949A1 claims a sheath structure with longitudinal tracts that seal against an arthroscopic instrument while defining separate outer lumens and at least one drainage lumen for fluid egress. It is a fluid-management and cannula-design claim, filed by Cannuflow in March 2016, and sits squarely in the A61M territory that touches over a third of all records in this dataset. Anyone designing a sheath or cannula intended to manage fluid extravasation during arthroscopy should review this claim's tract and lumen geometry specifically, since that structural approach is what the claim protects rather than the general concept of fluid drainage.
Research Arthroscopic Instruments and Visualization in depth with Eureka
Go past this page: query the whole arthroscopic instruments and visualization corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.